生物程序容器市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按容器類型、按應用、最終用戶、地區和競爭細分

預計生物程序容器市場在預測期內將出現令人印象深刻的成長。這可以歸因於生物製藥行業對自動化和機器學習實施的需求不斷成長，以及全球範圍內為開發新產品而引入技術先進的產品。生物程序容器是生物製藥製造程序的關鍵組成部分，為傳統不銹鋼設備提供了可靠且經濟高效的替代方案。在過去的幾年中，與生物程序容器相關的重大發展和趨勢已經出現。拋棄式生物程序容器的採用是由其靈活性、可擴展性和成本效益推動的。智慧感測器和物聯網 (IoT) 正在改變生物製藥行業，生物程序容器也不例外。生物程序容器現在採用智慧感測器進行設計，可即時監測和控制溫度、pH 值和溶解氧水平等關鍵工藝參數。這使得生物製藥製造商能夠最佳化其工藝、減少浪費並提高產品品質。與生物程序容器相關的主要挑戰之一是標準化。目前，生物程序容器尚無行業標準，每個製造商可能有自己的設計、材料和製造程序。缺乏標準化可能使生物製藥製造商在比較和選擇生物程序容器時面臨挑戰，從而導致效率低下和成本增加。與傳統不銹鋼設備相比，生物程序容器具有多種優勢，包括減少資本支出、提高靈活性和提高效率。隨著生物製藥製造商尋求最佳化其生產流程並降低成本，預計生物程序容器市場在未來幾年將繼續成長。可擴展性是與生物程序容器相關的另一個挑戰。生物製藥製造商可能需要快速擴大或縮小其生產流程，以滿足不斷變化的需求。生物程序容器的設計必須能夠適應生產中的這些變化，同時又不影響產品品質或效率。這可能具有挑戰性，因為生物程序容器可能需要針對特定​​應用進行客製化，並且可能不易擴展。生物程序容器通常用於生物製藥行業的細胞培養。這些容器旨在支持細胞的生長和生產，並且可以輕鬆客製化以滿足不同細胞系的特定需求。生物程序容器還用於基因治療，涉及將遺傳物質轉移到患者的細胞中以治療或預防疾病。這些容器用於培養和生產基因治療中使用的病毒載體，並且可以輕鬆修改以滿足不同載體系統的特定需求。

對生物製藥產品的需求不斷增加

過去幾年，由於人口老齡化、慢性病發病率上升以及對更有效治療方法的需求，對生物製藥產品的需求一直在穩步成長。與傳統製造方法相比，生物程序容器具有多種優勢，包括更大的靈活性、更低的污染風險和更低的成本，使其成為尋求提高產能的公司的有吸引力的選擇。隨著製造商尋求更靈活的解決方案，可以輕鬆適應不同的生產流程，我們預計生物程序容器設計將出現更多的客製化化和模組化。這將有助於降低成本並提高效率，同時仍保證生物製藥產品的品質和純度。

擴大採用拋棄式技術

生物程序容器是拋棄式技術的關鍵組成部分，該技術在生物製藥行業迅速受到關注。與傳統不銹鋼設備相比，這些技術具有多種優勢，包括較低的資本成本、減少的清潔和驗證要求以及更快的周轉時間。隨著拋棄式技術的採用不斷增加，對生物程序容器的需求也隨之增加。拋棄式技術已經徹底改變了生物製藥製造，我們預計該領域將持續成長。這將包括開發新型生物程序容器以及其他拋棄式組件，例如過濾器和泵。

對具有成本效益和高效的生產方法的需求不斷成長

生物程序容器的設計具有成本效益和高效性，使其成為尋求降低製造成本和提高產能的公司的有吸引力的選擇。與傳統的不銹鋼設備相比，生物程序容器需要更少的設置和清潔時間，從而縮短周轉時間並提高生產率。此外，生物程序容器可以客製化以滿足特定的客戶要求，從而在製造過程中實現更大的靈活性和效率。 GE醫療集團於2019年推出了新型生物反應器系統。ReadyToProcess WAVE 25是拋棄式生物反應器系統，可用於細胞培養和發酵過程。該系統具有預組裝的拋棄式生物程序容器，可以輕鬆整合到現有的製造程序中。生物程序容器通常由耐生物製藥產品的材料製成，旨在最大限度地降低污染風險。這有助於確保生物製藥產品的品質和純度，這對於法規遵從性和患者安全至關重要。

COVID-19 大流行的影響

COVID-19 大流行對生物製藥行業產生了重大影響，世界各地的公司都在加大疫苗和其他生物製品的生產。生物程序容器在這一努力中發揮了關鍵作用，使公司能夠迅速擴大生產規模並滿足對這些產品不斷成長的需求。隨著這一流行病繼續影響世界各地的人口，對生物程序容器的需求可能會保持強勁。

更加關注永續性和環境友好性

永續性和環境友好性對於生物製藥製造商來說變得越來越重要。許多公司現在專注於減少碳足跡並最大限度地減少浪費。生物程序容器在這一趨勢中發揮著重要作用，因為它們專為拋棄式應用而設計，減少了清潔和滅菌過程的需求。此外，許多生物程序容器製造商正在使用環保材料和製造程序來減少對環境的影響。默克於 2020 年推出了 Mobius MyWay 產品組合，其中包括一系列拋棄式生物程序容器、過濾產品和其他組件。 MyWay 產品組合旨在為不同的生物製藥製造程序提供客製化解決方案。生物程序容器設計為拋棄式使用，這意味著它們在使用後可以輕鬆處置。這消除了耗時的清潔和滅菌過程，從而可以提高整體製造效率。此外，生物程序容器可以預先組裝和預先消毒，這進一步減少了設置所需的時間和精力。

技術不斷進步

生物程序容器技術的進步也促進了市場的成長。例如，高性能薄膜和塗層的開發使生物程序容器能夠承受更極端的條件，例如高壓和高溫。此外，智慧感測器和RFID技術的使用可以更好地控制和監控製造過程，提高產品品質和安全性。

在過去的三年裡，已經推出了多種與生物程序容器相關的產品，旨在提高生物製藥製造的效率、可靠性和性能。這些產品的發布採用了新的薄膜技術、先進的感測器和獨特的葉輪技術以及其他創新。隨著生物製藥行業的不斷發展，我們預計將會看到更多旨在提高生物程序容器的效率和可靠性的產品。總體而言，在預測期內，對生物製藥的需求不斷成長以及對更高效、更具成本效益的製造解決方案的需求預計將繼續推動生物程序容器市場的成長。

近期發展

• 2020 年，賽多利斯推出了 BIOSTAT STR 拋棄式生物反應器，專為大規模細胞培養過程而設計。該生物反應器具有獨特的搖擺運動，模仿攪拌罐生物反應器的溫和攪拌，確保一致的混合和氧氣轉移。該系統還包括一系列用於即時監測和控制生物過程的感測器。
• 2020 年，頗爾公司推出了 Allegro 拋棄式系統，專為生物製藥製造應用而設計。該系統包括一系列拋棄式容器，包括袋子、管道和連接器，專為流體管理、過濾和生物反應器應用而設計。 Allegro 系統旨在降低污染風險並提高工藝靈活性和可擴展性。
• 2019 年，賽默飛世爾科技推出了 HyPerforma 拋棄式生物反應器，專為高密度細胞培養過程而設計。該生物反應器採用了新的薄膜技術，可以增強氧氣傳輸、更好的混合併改善 pH 控制。該系統還配備先進的感測器，用於即時監測和控制生物過程。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

• 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 考慮學習的年份
  • 主要市場細分

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要行業合作夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量和驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D 生物程序容器、3D 生物程序容器、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
  • 按公司分類 (2022)
• 市場地圖
  • 按集裝箱類型
  • 按應用
  • 由最終用戶
  • 按地區

第 6 章：北美生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D、3D、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D、3D、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D、3D、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞

第 9 章：南美生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D、3D、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲生物程序容器市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按容器類型（2D 生物程序容器、3D 生物程序容器、其他容器和配件）
  • 按應用（上游工藝、下游工藝、工藝開發）
  • 按最終用戶（生物製藥公司、生命科學研發公司、其他）
  • 按國家/地區
• MEA：國家分析
  • 南非生物程序容器
  • 沙烏地阿拉伯生物程序容器
  • 阿拉伯聯合大公國生物程序容器

第 11 章：市場動態

• 司機
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球生物程序容器市場：SWOT 分析

第 14 章：波特的五力分析

• 行業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• 商業概覽
• 產品供應
• 最近的發展
• 財務（據報導）
• 主要人員
• SWOT分析
  • Thermo Fisher Scientific Inc.
  • Cytiva Europe GmbH.
  • Saint-Gobain Group.
  • Lonza Group AG.
  • Avantor Funding Inc.
  • Merck KGaA.
  • Sartorius AG.
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

第 16 章：戰略建議

Bioprocess Containers market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in the biopharmaceutical industry, along with the introduction of technologically advanced products for the development of novel products across the globe. Bioprocess containers are a critical component of the biopharmaceutical manufacturing process, providing a reliable and cost-effective alternative to traditional stainless-steel equipment. Over the past few years, there have been significant developments and trends related to bioprocess containers. The adoption of single-use bioprocess containers has been driven by their flexibility, scalability, and cost-effectiveness. Smart sensors and the Internet of Things (IoT) are transforming the biopharmaceutical industry, and bioprocess containers are no exception. Bioprocess containers are now being designed with smart sensors that provide real-time monitoring and control of critical process parameters such as temperature, pH, and dissolved oxygen levels. This enables biopharmaceutical manufacturers to optimize their processes, reduce waste, and improve product quality. One of the main challenges related to bioprocess containers is standardization. Currently, there are no industry-wide standards for bioprocess containers, and each manufacturer may have their own design, material, and manufacturing process. This lack of standardization can make it challenging for biopharmaceutical manufacturers to compare and select bioprocess containers, which can lead to inefficiencies and added costs. Bioprocess containers offer several advantages over traditional stainless-steel equipment, including reduced capital expenditures, improved flexibility, and increased efficiency. The market for bioprocess containers is expected to continue to grow in the coming years as biopharmaceutical manufacturers seek to optimize their production processes and reduce costs. Scalability is another challenge related to bioprocess containers. Biopharmaceutical manufacturers may need to scale up or down their production processes quickly to meet changing demand. Bioprocess containers must be designed to accommodate these changes in production without compromising product quality or efficiency. This can be challenging, as bioprocess containers may need to be customized for specific applications and may not be easily scalable. Bioprocess containers are commonly used for cell culture in the biopharmaceutical industry. These containers are designed to support the growth and production of cells and can be easily customized to meet the specific needs of different cell lines. Bioprocess containers are also used in gene therapy, which involves the transfer of genetic material into a patient's cells to treat or prevent disease. These containers are used to culture and produce the viral vectors used in gene therapy and can be easily modified to meet the specific needs of different vector systems.

Increasing Demand for Biopharmaceutical Products

The demand for biopharmaceutical products has been increasing steadily over the past few years, driven by an aging population, rising incidence of chronic diseases, and the need for more effective treatments. Bioprocess containers offer several advantages over traditional manufacturing methods, including greater flexibility, reduced risk of contamination, and lower costs, making them an attractive option for companies looking to increase their production capacity. We can expect to see more customization and modularization in bioprocess container design as manufacturers look for more flexible solutions that can be easily adapted to different production processes. This will help to reduce costs and improve efficiency while still ensuring the quality and purity of biopharmaceutical products.

Growing Adoption of Single-use Technologies

Bioprocess containers are a key component of single-use technologies, which are rapidly gaining traction in the biopharmaceutical industry. These technologies offer several advantages over traditional stainless-steel equipment, including lower capital costs, reduced cleaning and validation requirements, and faster turnaround times. As the adoption of single-use technologies continues to increase, so too will the demand for bioprocess containers. Single-use technology has already revolutionized biopharmaceutical manufacturing, and we can expect to see continued growth in this area. This will include the development of new types of bioprocess containers, as well as other single-use components such as filters and pumps.

Growing demand for Cost-effective and efficient production methods

Bioprocess containers are designed to be cost-effective and efficient, making them an attractive option for companies looking to reduce manufacturing costs and increase production capacity. Compared to traditional stainless-steel equipment, bioprocess containers require less time for setup and cleaning, resulting in faster turnaround times and greater productivity. In addition, bioprocess containers can be customized to meet specific customer requirements, allowing for greater flexibility and efficiency in the manufacturing process. GE Healthcare launched a new bioreactor system in 2019. The ReadyToProcess WAVE 25 is a single-use bioreactor system that can be used for cell culture and fermentation processes. The system features a pre-assembled single-use bioprocess container and can be easily integrated into existing manufacturing processes. Bioprocess containers are typically made from materials that are resistant to biopharmaceutical products and are designed to minimize the risk of contamination. This can help ensure the quality and purity of biopharmaceutical products, which is critical for regulatory compliance and patient safety.

Effect of the COVID-19 Pandemic

The COVID-19 pandemic has had a significant impact on the biopharmaceutical industry, with companies around the world ramping up production of vaccines and other biologics. Bioprocess containers have played a critical role in this effort, enabling companies to rapidly scale up production and meet the growing demand for these products. As the pandemic continues to affect populations around the world, the demand for bioprocess containers is likely to remain strong.

Increased Focus on Sustainability and Environmental Friendliness

Sustainability and environmental friendliness are becoming increasingly important for biopharmaceutical manufacturers. Many companies are now focused on reducing their carbon footprint and minimizing waste. Bioprocess containers are playing a significant role in this trend, as they are designed for single-use applications, reducing the need for cleaning and sterilization processes. Moreover, many bioprocess container manufacturers are using environment-friendly materials and manufacturing processes to reduce their impact on the environment. Merck launched its Mobius MyWay portfolio in 2020, which includes a range of single-use bioprocess containers, filtration products, and other components. The MyWay portfolio is designed to provide customized solutions for different biopharmaceutical manufacturing processes. Bioprocess containers are designed for single use, which means they can be easily disposed of after use. This eliminates the need for time-consuming cleaning and sterilization processes, which can improve overall manufacturing efficiency. Additionally, bioprocess containers can be pre-assembled and pre-sterilized, which further reduces the time and effort required for setup.

Growing Technological Advancements

Advancements in bioprocess container technology have also contributed to the growth of the market. For example, the development of high-performance films and coatings has enabled bioprocess containers to withstand more extreme conditions, such as high pressures and temperatures. In addition, the use of smart sensors and RFID technology has enabled greater control and monitoring of the manufacturing process, improving product quality and safety.

The past three years have seen several product launches related to bioprocess containers that have aimed to improve the efficiency, reliability, and performance of biopharmaceutical manufacturing. These product launches have incorporated new film technology, advanced sensors, and unique impeller technology, among other innovations. As the biopharmaceutical industry continues to evolve, we can expect to see further product launches aimed at improving the efficiency and reliability of bioprocess containers. Overall, the increasing demand for biopharmaceuticals and the need for more efficient and cost-effective manufacturing solutions are expected to continue to drive the growth of the bioprocess container market during the forecast period.

Recent Development

• In 2020, Sartorius launched its BIOSTAT STR single-use bioreactor, designed for large-scale cell culture processes. The bioreactor features a unique rocking motion that mimics the gentle agitation of stirred-tank bioreactors, ensuring consistent mixing and oxygen transfer. The system also includes a range of sensors for real-time monitoring and control of the bioprocess.
• In 2020, Pall Corporation launched its Allegro single-use systems, designed for biopharmaceutical manufacturing applications. The system includes a range of single-use containers, including bags, tubing, and connectors, designed for fluid management, filtration, and bioreactor applications. The Allegro system is designed to reduce contamination risks and increase process flexibility and scalability.
• In 2019, Thermo Fisher Scientific launched its HyPerforma Single-Use Bioreactor, designed for high-density cell culture processes. The bioreactor incorporates a new film technology that allows for enhanced oxygen transfer, better mixing, and improved pH control. The system also features advanced sensors for real-time monitoring and control of the bioprocess.

Market Segmentation

Global Bioprocess Containers market is further segmented on the basis of type of containers, application, end user, and region. Based on the type of containers, the market can be segmented into 2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers, and Accessories. Based on application, the market can be further split into upstream process, downstream process, and process development. Based on end users, the market can be further divided into Biopharmaceutical Companies, Life Science R&D Companies, and Others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global bioprocess containers market on account of the established biopharmaceutical industry and the increasing adoption of single-use technologies in these regions.

Market Players

Thermo Fisher Scientific Inc., Cytiva Europe GmbH., Saint-Gobain Group., Lonza Group AG., Avantor Funding Inc., Merck KGaA., Sartorius AG., CellBios Healthcare and Lifesciences Pvt Ltd., Cole-Parmer Instrument Co., Biomass Ventures Pte Ltd. are some of the leading players operating in the Global Bioprocess Containers Market.

Report Scope:

In this report, global Bioprocess Containers market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Bioprocess Containers Market, By Type of Containers:

• 2D Bioprocess Containers
• 3D Bioprocess Containers
• Other Containers and Accessories

Bioprocess Containers Market, By Application:

• Upstream Process
• Downstream Process
• Process Development

Bioprocess Containers Market, By End User:

• Biopharmaceutical Companies
• Life Science R&D Companies
• Others

Bioprocess Containers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Containers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Type of Containers
  • 5.3.2 By Application
  • 5.3.3 By End Users
  • 5.3.4 By Region

6. North America Bioprocess Containers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioprocess Containers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Containers
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bioprocess Containers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Containers
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bioprocess Containers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Containers
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bioprocess Containers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bioprocess Containers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Containers
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bioprocess Containers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Containers
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bioprocess Containers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Containers
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bioprocess Containers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Containers
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bioprocess Containers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Containers
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bioprocess Containers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bioprocess Containers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Containers
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bioprocess Containers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Containers
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bioprocess Containers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Solution
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Development Model
      • 8.3.3.2.4. By Industry
  • 8.3.4. South Korea Bioprocess Containers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Containers
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bioprocess Containers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Containers
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bioprocess Containers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bioprocess Containers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Containers
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bioprocess Containers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Containers
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bioprocess Containers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Containers
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bioprocess Containers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bioprocess Containers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Containers
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Containers
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bioprocess Containers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Containers
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Bioprocess Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Thermo Fisher Scientific Inc.
  • 15.6.2 Cytiva Europe GmbH.
  • 15.6.3 Saint-Gobain Group.
  • 15.6.4 Lonza Group AG.
  • 15.6.5 Avantor Funding Inc.
  • 15.6.6 Merck KGaA.
  • 15.6.7 Sartorius AG.
  • 15.6.8 CellBios Healthcare and Lifesciences Pvt Ltd.
  • 15.6.9 Cole-Parmer Instrument Co.
  • 15.6.10 Biomass Ventures Pte Ltd.

16. Strategic Recommendations